Diana Velluto

Diana Velluto is a Research Assistant Professor of Surgery at the Diabetes Research Institute, where she develops nanotechnologies for targeted immunotherapies. Her work focuses on customizable nanoparticles (DIANA) to enhance beta-cell replacement therapies for type 1 diabetes (T1D) and explores applications in cancer treatment.

Research Interests

• Nanotechnology for localized drug delivery
• Beta-cell replacement therapies
• Immunosuppression without systemic side effects
• Integration of nanotechnology with stem cell and gene therapy

Her research, reported in over 30 publications and three patents, aims to extend the applicability of pancreatic islet transplantation. Recent work includes the Pharmaceutics 2024 publication on DIANA's spatiotemporal distribution in inflammation sites, highlighting trends in targeted therapies and controlled release systems.

Laboratory & Collaborations

• DIANA nanoparticle development for immunoregulation
• Collaborations in nanomedicine, diabetes, and oncology